000 01388 a2200445 4500
005 20250518051625.0
264 0 _c20200323
008 202003s 0 0 eng d
022 _a1573-7403
024 7 _a10.1007/s11102-019-00978-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSnyders, Travis
245 0 0 _aIpilimumab-induced hypophysitis, a single academic center experience.
_h[electronic resource]
260 _bPituitary
_cOct 2019
300 _a488-496 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents, Immunological
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypophysitis
_xchemically induced
650 0 4 _aIpilimumab
_xadverse effects
650 0 4 _aMale
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aProgression-Free Survival
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
700 1 _aChakos, Daniel
700 1 _aSwami, Umang
700 1 _aLatour, Emile
700 1 _aChen, Yiyi
700 1 _aFleseriu, Maria
700 1 _aMilhem, Mohammed
700 1 _aZakharia, Yousef
700 1 _aZahr, Roula
773 0 _tPituitary
_gvol. 22
_gno. 5
_gp. 488-496
856 4 0 _uhttps://doi.org/10.1007/s11102-019-00978-4
_zAvailable from publisher's website
999 _c29922132
_d29922132